Immediate Impact
59 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Works of Jonas Häggström being referenced
Key design considerations for adaptive clinical trials: a primer for clinicians
2018
Use of Quantitative Pharmacology in the Development of HAE1, a High-Affinity Anti-IgE Monoclonal Antibody
2008
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jonas Häggström | 42 | 16 | 13 | 30 | 30 | 8 | 208 | |
| Antonio Carlos Pedroso de Lima | 35 | 15 | 14 | 21 | 41 | 18 | 253 | |
| Nicolas Scheuer | 28 | 29 | 47 | 26 | 55 | 12 | 291 | |
| Ken Getz | 18 | 6 | 6 | 28 | 78 | 16 | 198 | |
| Kelly Plueschke | 54 | 4 | 16 | 21 | 27 | 12 | 263 | |
| Scott Askin | 21 | 6 | 8 | 30 | 68 | 5 | 237 | |
| Zhiheng Xu | 14 | 6 | 7 | 15 | 11 | 15 | 198 | |
| Kenneth Quinto | 73 | 13 | 13 | 15 | 19 | 9 | 229 | |
| Paul de Jong | 6 | 1 | 37 | 22 | 18 | 8 | 254 | |
| Lucy Shneyer | 27 | 7 | 11 | 17 | 7 | 12 | 215 | |
| Kimberly A. Mc Cord | 29 | 17 | 11 | 15 | 59 | 9 | 270 |
All Works
Login with ORCID to disown or claim papers
Loading papers...